Memantine is licensed for moderate-to-severe Alzheimer's disease. Unlike acetylcholinesterase inhibitors, it acts on a different receptor system. Which mechanism best describes its action?
Choose one answer
Questions and lessons can't be printed or saved as a PDF.
MRCPsych · Paper A
Log inPick your answer. Then see why.
Memantine is licensed for moderate-to-severe Alzheimer's disease. Unlike acetylcholinesterase inhibitors, it acts on a different receptor system. Which mechanism best describes its action?
Choose one answer